Effect of Metabolic Surgery on Live Birth Rate of Offspring in Obesity Polycystic Ovarian Syndrome Patients
Polycystic Ovary Syndrome, Severe Obesity, Laparoscopic Sleeve Gastrectomy
About this trial
This is an interventional treatment trial for Polycystic Ovary Syndrome focused on measuring Polycystic Ovary Syndrome, Severe Obesity, Laparoscopic Sleeve Gastrectomy, Live Birth Rate
Eligibility Criteria
Inclusion Criteria:
- aged from 18 to 45, not menopause have PCOS which is diagnosed according to 2003 Rotterdam criteria have been treated with behavioral and drugs intervention for 3 months but are ineffective have steady or steady weight gain over 5 years, BMI>35kg/m2, or BMI>30kg/m2 with one of the metabolic disorders such as impaired glucose tolerance, cardiovascular disease, fatty liver, lipid metabolism disorders, sleep apnea syndrome
Exclusion Criteria:
- Except for serious complications (cardiovascular events and recent significant liver, kidney or lung disease within 3 months) high blood pressure (>160/100mmHg) active infection secondary diabetes pregnancy alcohol abuse surgical contraindications
Sites / Locations
- Renji Hospital Affiliated to Shanghai Jiaotong University School of MedicineRecruiting
Arms of the Study
Arm 1
Experimental
Laparoscopic sleeve gastrectomy
Laparoscopic sleeve gastrectomy on severe obesity PCOS patients